ABSTRACT. At least two biotypes were observed at the 2nd passage stage after the isolation of Foot-and-mouth disease Virus (FMDV) O/ JPN/2000 strain. These 2 types of viruses differed from their plaque phenotypes and were distinguishable by using a monoclonal antibody (MAb) 64G8 that was made for the FMDV O/JPN/2000 strain. One of these 2 biotypes formed small plaque (SP) and with immuno staining showed a positive reaction to MAb 64G8, while the other formed clear large plaque (LP) and did not react with MAb 64G8. The amino acid sequences of the capsid coding region (VP1-VP4) of the SP virus (SPV) and the LP virus (LPV) revealed two substitutions on the 133rd amino acid in VP2, and the 56th amino acid in VP3. These amino acid changes of SPV and LPV are Asn to Asp, Arg to His, respectively. The Arg of the 56th amino acid in VP3 that have been known as critical position of cell culture adapted virus. Only LPV showed high pathogenicity in suckling mice, and its LD 50 was calculated to be about 10 2 TCID 50 /0.1 ml. These results showed that the SPV that existed at the 2nd passage stage from isolation was a low virulence virus, which may suggest why the pathogenicity of O/JPN/2000 did not show clear symptoms in infected cattle. KEY WORDS: FMDV, monoclonal antibody, O/JPN/2000, pathogenicity, plaque.
Foot-and-mouth disease virus (FMDV) is a member of the family Picornaviridae, genus Aphthovirus. FMDV is the causative agent of Foot-and-mouth disease (FMD).
FMD is one of the most important contagious diseases of cloven-hoofed animals, most significantly cattle, pigs, and sheep. FMDV-infected animals show vesicles on the mouth, nostrils, and around the breasts and feet as typical lesions.
In Japan, an FMD outbreak occurred in 2000, after an interval of 92 years. We isolated the FMDV designated O/ JPN/2000 strain from cattle that belonged to the PanAsia lineages in a member of the Middle East -South Asia (ME-SA) topotype [8, 18] . At nearly the same time around 2000, some outbreaks in PanAsia lineages occurred in Taiwan, South Korea, and the United Kingdom [3, 10, 11, [20] [21] [22] . The sensitivity of the host animals and the strain's pathogenicity were variable. In an outbreak in Taiwan in 1999, the O/TAW/1999 strain showed sensitivity to mainly Chinese yellow cattle in the field though the virus did not cause the development of vesicular lesions in cattle in the field or in animal experimentation [3] . The O/SKR/2000 strain was identified with the typical clinical signs of FMDV both in dairy and native cattle [11, 22] . In an outbreak in the United Kingdom in 2001, the O/UKG/2001 strain showed mild symptoms especially in sheep, and it seemed to be one of the causes of widespread outbreak [12] .
The characteristics of the O/JPN/2000 strain was seen to be atypical. It showed mild clinical signs in Japanese black cattle, which was confined to slight erosions and ulcers in the mouth and nose. In particular, it presented no lesion in the feet [18] . The results of the experimental infection of the strain using Japanese black cattle, Holstein cattle, pigs, goats, and sheep were as follows. Pigs showed typical symptoms, but Japanese black cattle showed atypical symptoms which were limited to mild symptoms and lesions. Furthermore, Holstein cattle exhibited no clinical signs, and sheep and goats were not susceptible [19] . These different clinical signs in the animals seemed to indicate a diversification of both pathogenicity and susceptibility in host animals of the PanAsia lineage.
Sa-carvalho et al. reported that the 56th amino acid in VP3 as the critical determinant of plaque phenotype and pathogenicity to cattle. The genetically engineered Arg coding virus at the 56th amino acid in VP3 was highly attenuated in cattle and formed small plaque [17] . In addition, some high-passage-number cases of cell culture type O virus showed amino acid changes to Arg from His at the 56th amino acid in VP3 [9, 13, 17] .
In this report, we focused on plaque phenotypes of the O/ JPN/2000 strain in order to clarify this strain's characteristics. Therefore, we cloned each plaque of the O/JPN/2000 strain, and the characters of each plaque phenotype were compared by genome sequencing and infection to suckling mice. Moreover we made the MAbs to O/JPN/2000 and attempted to distinguish these plaque phenotypes.
MATERIALS AND METHODS
Cell lines, virus, and plaque assays: Primary bovine kidney (BK) cells and IBRS-2 were maintained with Eagle's minimum essential medium (MEM) (Nissui Pharmaceutical Co., Ltd. Tokyo, Japan) with 0.3% of tryptose phosphate broth (TPB) (DIFCO Laboratories, Detroit, Mich.) supplemented with 0.3 mg/ml of L-glutamine, 1.5% of 7.5% NaHCO3, and 5% fetal bovine serum (FBS) (GIBCO U.S.A.). Confluent cultured monolayer of BK cells and IBRS-2 in 6-well plates were prepared for plaque cloning and plaque assay.
The FMDV was isolated using BK cells in Japan in 2000. The isolated virus was designated O/JPN/2000 strain. OJPN/2000 strain of the 4th passage on BK cells was plaque-purified. The viruses were inoculated 0.2 ml per well and incubated at 37°C in 5% CO 2 for 1 hr and tilted every 15 min. After washing the well 3 times with phosphate buffered saline (PBS), 3 ml of 1.5% methyl cellulose in MEM was overlaid. They were stained with 0.2% crystal violet or were stained with immuno peroxide monolayer assay (IPMA) after 24 hr, 42 hr, and 60 hr incubation periods.
MAbs production, virus neutralization test of MAbs and IPMA:
Eight-week-old BALB/c mice were immunized with emulsion of purified FMDV O/JPN/2000 strain and Freund's complete adjuvant. The second immunization was carried out using Freund's incomplete adjuvant with the same antigen. The final dose was administrated without adjuvant. All immunization was done intraperitoneally. Hybridoma was made using fuse-immunized mice spleen cells and myeloma cells with polyethylene glycol #4000 (Merck Darmstadt, Germany). Hybridomas were grown in RPMI 1640 medium (Nissui) supplemented with 20% FBS. The isotype of the MAbs were determined using a mouse monoclonal isotyping kit (Serotec Ltd.UK).
Neutralization activities of MAbs were determined using O/JPN/2000, SPV, and LPV, respectively. Neutralization assays were performed according to the OIE manual. Briefly, serial dilutions of MAbs were mixed in an equal volume of 100 TCID 50 of virus. The mixtures were inoculated at 37°C for 1 hr and the IBRS-2 cells suspended in medium were then added to each well. After incubation at 37°C for 4 days, the antibody titer was expressed as a reciprocal of the highest dilution of MAb that completely inhibited the cytopathic effect (CPE).
Mainly, two MAbs (64G8 and 62G12) were used with the immuno stain for the plaque clones. The IPMAs were performed on plates infected with SPV and LPV, respectively. Each virus was inoculated to a monolayer of IBRS-2 cells or BK cells. After being overlayed with methylcellulose medium, the cultures were inoculated for 24 hr at 37°C. Monolayer cells were fixed by 70% acetone for 15 min. The cells were washed with PBS, pH7.4, and hybridoma culture fluids or diluted ascites fluids were added and the solutions were then incubated at 37°C for 90 min. After washing the cells with PBS three times, diluted Horseradish peroxidaseconjugated Goat IgG fraction to mouse immunoglobulin (IgG, IgA, IgM) (ICN Biomedicals. Inc U.S.A./CAPEL) in PBS was added to the cells. After 45 min at 37°C, the cells were washed in the manner described above, and developed using 3'3-diaminobenzidine solution.
Infection of suckling mice: The animal experiments using suckling mice were performed according to the method described by Platt [15] . Three-to-five-day-old BALB/c suckling mice were inoculated intraperitoneally with 100 µl of each serial diluted virus (10 2 , 10 3 , 10 4 , and 10 5 TCID 50 ) with PBS (pH7.4). Suckling mice were observed for a week after inoculation. LD 50 was calculated using the ReedMuench method (1938) [16] .
RT-PCR, sequencing and sequence analysis: DNA sequencing of the structural protein coding region (VP1-VP4) of SPV and LPV was performed as follows: Viral RNA of the plaque-cloned viruses was extracted from the cultured fluid using a High Pure Viral RNA Extraction Kit (Roche Diagnostics, Indianapolis, Ind.). RT-PCR was carried out using Super script III one-step RT-PCR system (Invitrogen Corp, Carlsbad, Calif.) used the oligonucleotide primer sets VP4F and VP1R ( Table 1 ). The amplified fragments were electrophoresed in 1% agarose-Tris-acetic acid-EDTA (TAE) gel containing 0.5 mg /ml of ethidium bromide and DNA bands were visualized on a transilluminator. Target amplicon was purified from TAE gel using a Wizard Plus SV Minipreps DNA Purification System (Promega, Madison, Wis.). Purified fragments were cloned into vectors using the pGEM-T Easy Vector System (Promega). Plasmid DNA was sequenced using a Big Dye Terminator Sequencing kit (Applied Biosystems, Foster City, Calif.) employing selected primers (Table 1 ) and analyzed on a 3130 genetic analyzer (Applied Biosystems). Nucleotide and amino acid sequences were assembled and analyzed using Genetyx Software (Genetyx Corporation Tokyo, Japan).
RESULTS

Comparison of in vitro characteristics between 2 plaque phenotypes:
O/JPN/2000 was isolated by BK cells. The two plaque phenotypes, SPV and LPV, were present in the 2nd passage cultured fluid from isolation. SPV showed weak plaque-forming ability. The SPV was hard to spread and to form clear spot through 60 hr inoculation under 1.5% of methylcellulose (Fig. 1) . The LPV was seen to create clear plaque under 1.5% methylcellulose (Fig. 1) . SP appeared to exist approximately more than 40% in the 2nd passage O/ JPN/2000 strain after virus isolation (data not shown). 
Finally, we were able to obtain cloned SPV and LPV after 3 times of plaque clonings from the 4th passage virus in BK cells (Fig. 1) . After the plaque cloning, one-step growth tests were performed on SPV and LPV. The growth speed of each phenotype in cultured cells was not distinctly different and the time necessary for CPE to appear in SPV was shorter than that of LPV (data not shown).
MAbs character and reaction to SPV and LPV:
We were able to obtain the some clones of hybridoma. MAb 64G8 showed neutralization ability for SPV, and MAb 62G12 showed neutralization ability for both plaque clones SPV and LPV (Table 2) . Their neutralization ability correlated with stain ability for IPMA (Fig. 2) , and could be used to distinguish between SP and LP. Their characteristics are shown in Table 2 .
Pathogenicity in suckling mice: All the mice inoculated with 10 5 TCID 50 of LPV died with or without severe symptoms such as panting weakness, or limb paralysis within 3 days post-inoculation (dpi). Similarly, the mice inoculated with 10 4 TCID 50 of LPV were dead within 4 dpi, and the survival rate of mice inoculated with 10 3 TCID 50 of LPV was less than 10%. The mice infected with LPV showed high mortality, and their survival rate was dose dependent (Fig.  3) . On the other hand, SPV did not show clear pathogenicity in suckling mice. Even 10 5 TCID 50 of SPV was not enough to create symptoms in more than 70% of inoculated mice (Fig. 3) . We could not detect viral RNA from any of the organs of symptomless mice inoculated with SPV from 1-4 dpi. This result demonstrated that SPV could not propagate in mice to a level sufficient to be detected by RT-PCR (data not shown). The LD 50 of LPV was estimated as approximately less than 10 2 TCID 50 , but LD 50 of SPV was over 10 5 TCID 50 . The LD 50 in suckling mice differed by over 10 3 times.
Comparison of amino acid sequence of structural proteins of each plaque phenotype: Genome sequencing of the structural protein coding region (VP1-VP4) was performed for comparison between both SPV and LPV. Genome sequencing analysis revealed amino acid substitutions in VP2 and VP3. There is neither amino acid deletion nor substitution in both VP1 and VP4. The two amino acid substitutions existed at the 133rd amino acid in VP2 and at the 56th amino acid in VP3. These substitutions of SPV and LPV were Asn to Asp in VP2, and Arg to His in VP3, respectively (Table 3) .
DISCUSSION
There were two different plaque phenotypes in O/JPN/ 2000 strain at the primary stage from virus isolation. Their plaque phenotypes were clearly different (Fig. 1) . It appeared that more than 40% SP existed in 2nd passage O/ JPN/2000 strain after virus isolation as determined by IPMA. The growth speed under a cultured cell condition was not distinctly different between each phenotype and the time necessary for the appearance of CPE in SPV was shorter than that of LPV (data not shown).
On the other hand, the pathogenicity of LPV in suckling mice was distinguishably stronger than that of SPV (Fig. 3) . Though suckling mice is known as a sensitive animal for FMDV diagnosis since early times [15] , SPV showed only remarkably low pathogenicity to suckling mice (Fig. 3) . Moreover, SPV and LPV were distinguished by MAb 64G8. Therefore MAb contribute to identify the SPV in mix population. It seemed that the MAb 64G8 recognize the antigenic site 4 of Arg of 56th amino acid in VP3 from the results of genome sequence comparisons. In the future, suckling mice and MAb 64G8 may be useful tool for more investigation of the pathogenicity of O/JPN/2000 strain SPV and LPV.
In the amino acid sequence supposed based on a result of the genome sequencing, amino acid in the VP1 of SPV and LPV did not show any changes. The 133rd amino acid in VP2 substitution between SPV and LPV was Asn and Asp, respectively, and is very close to the 134th and 135th amino acid of the heparin interacting region in VP2 [4, 7] . This may influence the strain's adaptation to cultured cells.
The 56th amino acid in VP3 substitution between SPV and LPV was Arg and His, respectively ( Table 3 ). The 56th amino acid in VP3 is known as a heparin sulfate binding site and influences plaque size and pathogenicity in cattle [1, 4-6, 7, 17] . As for FMDV typeO virus, the 56th amino acid in VP3 changes His to Arg along with the progress of the virus passage number [9, 13, 17] . Most of these cases showed that the total passage number reached to 50 or 60 times for 
